NCT04128852View on ClinicalTrials.gov

Post Marketing Clinical Follow up Study for MagnetOs Putty in Patients With Degenerative Disc Disease

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 11, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2023

Conditions
Degenerative Disc Disease
Interventions
DEVICE

MagnetOs Putty

MagnetOs Putty has a CE-mark (2115660CE01) as well as FDA 510(k) clearance (K171563/K181958).

Sponsors
All Listed Sponsors
collaborator

Factory CRO

INDUSTRY

collaborator

The London Clinic

OTHER

collaborator

Kuros BioSciences B.V.

INDUSTRY

lead

Kuros Biosurgery AG

INDUSTRY

NCT04128852 - Post Marketing Clinical Follow up Study for MagnetOs Putty in Patients With Degenerative Disc Disease | Biotech Hunter | Biotech Hunter